Cargando…
Immediate start of antiretroviral, why not?
Autores principales: | Matsuda, Elaine Monteiro, Coelho, Luana Portes Ozório, Ahagon, Cintia Mayumi, Campos, Ivana Barros, Brígido, Luís Fernando de Macedo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425641/ https://www.ncbi.nlm.nih.gov/pubmed/29936099 http://dx.doi.org/10.1016/j.bjid.2018.05.006 |
Ejemplares similares
-
Recent HIV infections: evaluation of a simple identification score for newly diagnosed patients
por: Matsuda, Elaine Monteiro, et al.
Publicado: (2022) -
COVID-19 in children: a case report of Multisystem Inflammatory Syndrome (MIS-C) in São Paulo, Brazil
por: Matsuda, Elaine Monteiro, et al.
Publicado: (2020) -
Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in São Paulo State, Brazil
por: Soldi, Giselle de Faria Romero, et al.
Publicado: (2019) -
SARS-CoV-2 testing among patients and healthcare professionals in an HIV outpatient clinic in Brazil
por: Matsuda, Elaine Monteiro, et al.
Publicado: (2022) -
Impact of covid-19 on people living with HIV-1: care and prevention indicators at a local and nationwide level, Santo André, Brazil
por: Matsuda, Elaine Monteiro, et al.
Publicado: (2022)